HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of GABA uptake inhibitors on posthypoxic myoclonus in rats.

Abstract
Male Sprague-Dawley rats developed posthypoxic myoclonus following 10-min cardiac arrest and resuscitation. Previous results showed that dysfunction of central GABAergic neurotransmission may contribute to the disease. In current studies, effects of GABA uptake inhibitors, guvacine hydrochloride (1,2,5,6-tetrahydro-3-pyridine carboxylic acid hydrochloride) and (+/-)-cis-4-hydroxynipecotic acid ([+/-]-cis-4-hydroxy-3-piperidine carboxylic acid), in the pathophysiology of posthypoxic myoclonus were investigated. Administration of guvacine (1 or 10 mg/kg, IP) or nipecotic acid (0.5 or 5 mg/kg, IP) significantly attenuated myoclonus scores of the animals. Tolerance to antimyoclonus effects of these two compounds did not develop after chronic administration (twice a day for 14 days) of guvacine (10 mg/kg, IP) or nipecotic acid (5 mg/kg, IP). On the other hand, tolerance was noticed with clonazepam (2.5 mg/kg, IP twice a day for 7 days). The results indicate that guvacine or nipecotic acid may be used in combination with (at reduced doses) or as alternatives to clonazepam to treat patients with the disease so as to reduce tolerance phenomenon usually associated with clonazepam.
AuthorsS P Jaw, B Nguyen, Q T Vuong, T A Trinh, M Nguyen, D D Truong
JournalBrain research bulletin (Brain Res Bull) Vol. 39 Issue 3 Pg. 189-92 ( 1996) ISSN: 0361-9230 [Print] United States
PMID8866696 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GABA Modulators
  • Nicotinic Acids
  • guvacine
  • Clonazepam
Topics
  • Animals
  • Clonazepam (pharmacology)
  • Dose-Response Relationship, Drug
  • GABA Modulators (pharmacology)
  • Male
  • Myoclonus (drug therapy)
  • Nicotinic Acids (pharmacology)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: